Results 111 to 117 of about 486 (117)
Some of the next articles are maybe not open access.
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Nature Medicine, 2018Yuting Sun +2 more
exaly
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Nature Reviews Cancer, 2008Ludger Hengst, Joyce M Slingerland
exaly
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Nature Reviews Clinical Oncology, 2017Mizuki Nishino +2 more
exaly
The evolving landscape of tissue‐agnostic therapies in precision oncology
Ca-A Cancer Journal for CliniciansVivek Subbiah +2 more
exaly
Interplay between β-lactamases and new β-lactamase inhibitors
Nature Reviews Microbiology, 2019Karen Bush, Patricia A Bradford
exaly
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Nature, 2009Michael A Milhollen +2 more
exaly
SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN
Ca-A Cancer Journal for Clinicians, 2005exaly